These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33338491)

  • 41. A novel strategy for physiologically based predictions of human pharmacokinetics.
    Jones HM; Parrott N; Jorga K; Lavé T
    Clin Pharmacokinet; 2006; 45(5):511-42. PubMed ID: 16640456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans.
    Luttringer O; Theil FP; Poulin P; Schmitt-Hoffmann AH; Guentert TW; Lavé T
    J Pharm Sci; 2003 Oct; 92(10):1990-2007. PubMed ID: 14502539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantification of the Impact of Partition Coefficient Prediction Methods on Physiologically Based Pharmacokinetic Model Output Using a Standardized Tissue Composition.
    Utsey K; Gastonguay MS; Russell S; Freling R; Riggs MM; Elmokadem A
    Drug Metab Dispos; 2020 Oct; 48(10):903-916. PubMed ID: 32665416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor.
    Duan J; Yong CL; Garneau M; Amad M; Bolger G; De Marte J; Montpetit H; Otis F; Jutras M; Rhéaume M; White PW; Llinàs-Brunet M; Bethell RC; Cordingley MG
    Xenobiotica; 2012 Feb; 42(2):164-72. PubMed ID: 21988548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global Sensitivity Analysis of the Rodgers and Rowland Model for Prediction of Tissue: Plasma Partitioning Coefficients: Assessment of the Key Physiological and Physicochemical Factors That Determine Small-Molecule Tissue Distribution.
    Yau E; Olivares-Morales A; Gertz M; Parrott N; Darwich AS; Aarons L; Ogungbenro K
    AAPS J; 2020 Feb; 22(2):41. PubMed ID: 32016678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An algorithm for evaluating potential tissue drug distribution in toxicology studies from readily available pharmacokinetic parameters.
    Poulin P; Dambach DM; Hartley DH; Ford K; Theil FP; Harstad E; Halladay J; Choo E; Boggs J; Liederer BM; Dean B; Diaz D
    J Pharm Sci; 2013 Oct; 102(10):3816-29. PubMed ID: 23878104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans.
    Jeong YS; Kim MS; Lee N; Lee A; Chae YJ; Chung SJ; Lee KR
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34072547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat.
    Ayyar VS; Song D; DuBois DC; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 2019 Aug; 370(2):318-326. PubMed ID: 31197020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method.
    Poulin P; Haddad S
    J Pharm Sci; 2012 Jun; 101(6):2250-61. PubMed ID: 22388869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An Accurate In Vitro Prediction of Human VD
    Berellini G; Lombardo F
    Drug Metab Dispos; 2019 Dec; 47(12):1380-1387. PubMed ID: 31578209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologically Based Models? A Feasibility Study Based on 12 Development Compounds.
    Parrott N; Manevski N; Olivares-Morales A
    Mol Pharm; 2022 Nov; 19(11):3858-3868. PubMed ID: 36150125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection.
    Theil FP; Guentert TW; Haddad S; Poulin P
    Toxicol Lett; 2003 Feb; 138(1-2):29-49. PubMed ID: 12559691
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Fagerholm U; Hellberg S; Alvarsson J; Arvidsson McShane S; Spjuth O
    Xenobiotica; 2021 Dec; 51(12):1366-1371. PubMed ID: 34845977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
    Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D
    Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical Compounds.
    Murad N; Pasikanti KK; Madej BD; Minnich A; McComas JM; Crouch S; Polli JW; Weber AD
    Drug Metab Dispos; 2021 Feb; 49(2):169-178. PubMed ID: 33239335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of Deoxypodophyllotoxin Disposition in Mouse, Rat, Monkey, and Dog by Physiologically Based Pharmacokinetic Model and the Extrapolation to Human.
    Chen Y; Zhao K; Liu F; Xie Q; Zhong Z; Miao M; Liu X; Liu L
    Front Pharmacol; 2016; 7():488. PubMed ID: 28018224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. QSAR model to predict K
    Umemori Y; Handa K; Sakamoto S; Kageyama M; Iijima T
    SAR QSAR Environ Res; 2022 Nov; 33(11):885-897. PubMed ID: 36420623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In silico human and rat Vss quantitative structure-activity relationship models.
    Gleeson MP; Waters NJ; Paine SW; Davis AM
    J Med Chem; 2006 Mar; 49(6):1953-63. PubMed ID: 16539383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling.
    Vlot AHC; de Witte WEA; Danhof M; van der Graaf PH; van Westen GJP; de Lange ECM
    AAPS J; 2017 Dec; 20(1):11. PubMed ID: 29204742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.